The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This clinical study is to observe the improvement of MHD (maintenance hemodialysis) patients,
quality of life，after applying therapy combining Auriculotherapy and Shengmai capsule. As a
compliment to each other, Traditional Chinese Medicine and Modern Medicine form a joint and
help improving life quality of MHD patients. Through the therapy, MHD patients, symptoms of
thirst are improved, the incidence of intradialytic hypotension is reduced, the intake of
water and sodium is lessen and the weight gain during dialysis is controlled, which
consequently reduce cardiovascular and cerebrovascular complications and eventually reduce
the mortality of MHD patients. Aiming to improve patients, thirst symptom and reduce the
incidence of intradialytic hypotension, this study prospectively followed 144 MHD patients
using multicenter prospective randomized crossover controlled clinical studies, using KT/V,
URR, improvement of thirst, blood pressure and cognitive assessment as observational index.
Multiple questionnaire surveys are conducted to understand patients, life quality from
different angle. The use of Auriculotherapy is simple and effective and Shengmai capsule
conforms to patients, syndrome, which is consistent with TCMs principle of "syndrome
differentiation and treatment"and the theory of preventive treatment. The study not only
expends the use of TMC in hemodialysis treatment, but also suggests a set of easy therapeutic
schedules to improve the quality of life in patients receiving hemodialysis treatment.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Beijing University of Chinese Medicine
Collaborators:
Beijing First Hospital of integrated Chinese and Western Medicine Dongfang Hospital Affiliated to Beijing University of Chinese Medicine Dongfang Hospital Beijing University of Chinese Medicine Wang Jing Hospital